PANACEABIO388.00

Panacea Biotec Limited

· Pharma & Health
₹ CrorePeersSAIPARENTHIKALINDOCODCALWINDLASHESTERBIOSOLARASYNCOMFMcap ₹2,378 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt21.022.223.723.7
Net Debt-66.5-63.1-43.7-43.7
Total Debt/Equity0.030.030.030.03
Net Debt/Equity-0.08-0.08-0.05-0.05
Total Debt/EBITDA-1.05-0.86-5.08-5.08
Net Debt/EBITDA3.322.439.37-19.95
Interest Coverage (EBIT/Interest)-15.86-15.65-6.23-6.23
Total Debt/Total Capital %2.442.602.782.78
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.